Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 459

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 459
---
 to the rate reconciliation and income taxes paid information. The ASU also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in this ASU are effective for public business entities for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Group is still evaluating the effect of the adoption of this guidance. ASU No. 2024 -03, Income Statement -ReportingComprehensive Income -ExpenseDisaggregation Disclosures (Subtopic 220 -40): Disaggregation of Income Statement Expenses (“ASU 2024 -03”), was issued in November 2024, which requires disclosure in the notes to the financial statements, of disaggregated information about certain costs and expenses that are included in expense line items on the face of the income statement. The requirements of ASU 2024 -03are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027 with early adoption permitted. The Company is currently evaluating the impact, if any, that the adoption of this standard will have on its Consolidated Financial Statements and disclosures. The Group does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material impact on the consolidated financial statements. 4. REVENUE During the second quarter of 2023, the Group made a decision to streamline its operations by terminating clinic services and suspending non -leadR&D projects. Norevenue was generated for the year ended December 31, 2024. For the years ended December 31, 2023 and 2022, all revenue came from provision of healthcare services in Hong Kong. 5. LONG-TERM INVESTMENT AND FAIR VALUE MEASUREMENT As of December31, 2024, the Group’s long -terminvestment consists of non -marketableinvestments with carrying value of $ 15,098,846and equity method investment at fair value option with carrying value of $ nil. As of December31, 2023, the Group’s long -terminvestment consists of non -marketableinvestments with carrying value of $ 16,098,846and equity method investment at fair value option with carrying value of $ nil. Non-marketable investments The Group’s non -marketableinvestments are investments in privately held companies without readily determinable fair values. The carrying value of the non -marketableinvestments are adjusted based on price changes from observable